Daewoong IDMC Confirms Bersiporocin Safety, Recommends Ph2 Trial
27 Oct 2025 //
PR NEWSWIRE
Daewoong Shares Ph 2 Bersiporocin Data at ATS 2025
03 Jun 2025 //
PR NEWSWIRE
Daewoong`s Bersiporocin Receives Positive IDMC Recommendation
29 Jul 2024 //
PR NEWSWIRE
Daewoong`s Bersiporocin Receives `Orphan Drug Designation` in Europe
29 Jan 2024 //
PR NEWSWIRE
Daewoong Pharmaceutical begins the first administration of the Bersiporocin
06 Feb 2023 //
PR NEWSWIRE
				
				 
				  			
 Market Place
 Sourcing Support